Chemoinformaics analysis of ISOPROPYL-TARTARIC-ACID
| Molecular Weight | 456.711 | nRot | 5 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 24 |
| Exact Molecular Weight | 456.36 | nRing | 5 |
| Solubility: LogS | -4.045 | nHRing | 0 |
| Solubility: LogP | 6.04 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 84.5121 |
| nHD | 2 | BPOL | 49.0219 |
| QED | 0.429 |
| Synth | 5.449 |
| Natural Product Likeliness | 3.271 |
| NR-PPAR-gamma | 0.82 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.03 |
| Pgp-sub | 0 |
| HIA | 0.015 |
| CACO-2 | -5.09 |
| MDCK | 0.000016 |
| BBB | 0.399 |
| PPB | 0.986613 |
| VDSS | 1.104 |
| FU | 0.0195951 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.533 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.87 |
| CYP2c9-inh | 0.12 |
| CYP2c9-sub | 0.584 |
| CYP2d6-inh | 0.069 |
| CYP2d6-sub | 0.438 |
| CYP3a4-inh | 0.181 |
| CYP3a4-sub | 0.149 |
| CL | 7.041 |
| T12 | 0.029 |
| hERG | 0.073 |
| Ames | 0.012 |
| ROA | 0.064 |
| SkinSen | 0.555 |
| Carcinogencity | 0.016 |
| EI | 0.039 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.603 |
| Antiviral | No |
| Prediction | 0.758763 |